Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.32, read 2026-11-04
Ethical does not pass the values gate
Price68.09 USD
Fair value72.45
Ethical score70.0/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-10-30Read Distribution73.76-7.7% to today ✓Markdown gives way to Distribution
2026-10-22Read Markdown73.87-7.8% to today ✓Accumulation gives way to Markdown first Markdown read since August
2026-10-16Read Accumulation73.86-7.8% to today Markup gives way to Accumulation first Accumulation read since October
2026-10-11Read Markup77.26-11.9% to today Accumulation gives way to Markup after a 5% rise in 9 days
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The Gorman-Rupp Company holds its Distribution at $68.09. Consolidating, no directional conviction, held for 5 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 5 days
Price at the screen
$68.09
Valuation
26.37 trailing · 22.84 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.28
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
35.76%
Below 33%
Interest-bearing debt is 35.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
14.36%
Below 49%
Money owed to the company is 14.4% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
The Gorman-Rupp's business is in a permissible area, but its interest-bearing debt is about 36% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GRC's ethical verdict changes
Today GRC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades above our $72.45 fair value estimate, 11.80% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 6.0% discount to the base estimate.
Third-party analyst targets: 3 covering, consensus Buy. The average target sits +23% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $72.45, with a range of $72.00 to $83.31, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Pumps Keep Industry Flowing Yet Shares Look Overpriced
Every factory floor or flood defence that needs reliable water movement ends up relying on specialised pumps. Gorman-Rupp makes those components and has grown revenue 8 percent while delivering an 8 percent profit margin and 15 percent return on equity. The business clears the ethical screen without issue, yet the shares sit well above our fair value of 67.47 dollars at the current 79.74 dollar price.
Forward earnings sit at 26.6 times, a multiple that already prices in continued steady growth. Three analysts still carry a buy rating with a 75 dollar median target, but that leaves little room for disappointment in either margins or demand. Without a clear moat to protect those returns, the valuation leaves no margin of safety and produces a zero opportunity rating.
Cyclical industrial spending can shift quickly when construction or farm investment slows, and any compression in multiples would widen the gap to fair value further. Currency moves and raw-material costs add another layer of pressure that the numbers do not yet reflect. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GRC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-06Distribution$68.09-7.7%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74.
2026-10-23Markdown$73.87+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown · changed$73.87+0.0%Entry 14
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$73.86+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$73.86+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Accumulation$73.86+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$73.86+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Accumulation$73.86+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
